Series Product Name Formula Executive Standard
APIs LEVOCARNITINE(FDA approved) C7H15O3N USP Edition, EP Edition More

LEVOCARNITINE(FDA approved)

[CAS#]: 541-15-1

×
Rivaroxaban(Not offered to patent protected area) C19H18ClN3O5S CORP. Standard More

Rivaroxaban(Not offered to patent protected area)

[CAS#]: 366789-02-8

×
Vildagliptin(Not offered to patent protected area) C17H25N3O2 CORP. Standard More

Vildagliptin(Not offered to patent protected area)

[CAS#]: 274901-16-5

×
Sitagliptin phosphate(Not offered to patent protected area) C16H20F6N5O6P CORP. Standard More

Sitagliptin phosphate(Not offered to patent protected area)

[CAS#]: 654671-77-9

×
Linagliptin(Not offered to patent protected area) C25H28N8O2 CORP. Standard More

Linagliptin(Not offered to patent protected area)

[CAS#]: 668270-12-0

×
Lapatinibditosylate(Not offered to patent protected area) C43H42ClFN4O10S3 CORP. Standard More

Lapatinibditosylate(Not offered to patent protected area)

[CAS#]: 388082-78-8

×
Sunitinib malate(Not offered to patent protected area) C26H33FN4O7 CORP. Standard More

Sunitinib malate(Not offered to patent protected area)

[CAS#]: 341031-54-7

×
Sorafenibtosylate(Not offered to patent protected area) C28H24ClF3N4O6S CORP. Standard More

Sorafenibtosylate(Not offered to patent protected area)

[CAS#]: 475207-59-1

×
TENOFOVIR(Not offered to patent protected area) C9H14N5O4P CORP. Standard More

TENOFOVIR(Not offered to patent protected area)

[CAS#]: 147127-20-6

×
LOXOPROFEN SODIUM C15H21O5Na JP16 More

LOXOPROFEN SODIUM

[CAS#]: 80382-23-6

×
LONAZOLAC CALCIUM C17H12CaClN2O2 CORP. Standard More

LONAZOLAC CALCIUM

[CAS#]: 75821-71-5

×
NEVIRAPINE(Not offered to patent protected area) C15H14N4O CORP. Standard More

NEVIRAPINE(Not offered to patent protected area)

[CAS#]: 129618-40-2

×